Responding to mounting international concern about the rise of drug-resistant infections, the UK Prime Minister, The Rt Hon David Cameron MP, commissioned Jim O'Neill in July 2014 to chair this review on antimicrobial resistance. By the summer of 2016, the Review will recommend a package of ...
The Review on Antimicrobial Resistance Chaired by Jim O’Neill. Tackling Drug Resistant Infections Globally: Final Report and Recommendations. 2016. Google Scholar Otter JA, et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital pe...
Responding to mounting international concern about the rise of drug-resistant infections, the UK Prime Minister, The Rt Hon David Cameron MP, commissioned Jim O'Neill in July 2014 to chair this review on antimicrobial resistance. By the summer of 2016, the Review will recommend a package of ac...
Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996;311:9–16.10.1097/00000441-199601000-00003Search in Google Scholar [2] O’Neill J. Tackling a global health crisis: initial steps. The Review on Antimicrobial Resistance Chaired by Jim O’Neill, 2015.Search in Google ...
Review on Antimicrobial Resistance. Securing new drugs for future generations: the pipeline of antibiotics.: Wellcome Trust/HM Government (UK); 2015. 6. Biswas, S., Brunel, J. M., Dubus, J. C., Reynaud-Gaubert, M. & Rolain, J. M. Colistin: an update on the antibiotic of the 21st...
Jim O’Neill. Review on Antimicrobial Resistance. London; 2016. https://amr-review.org/ [Accessed 28 September 2018]. Google Scholar [7] D.M. Sievert, P. Ricks, J.R. Edwards, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported...
Antimicrobial Resistance and Infection Control. 2016;5:1-11 [26] Stone PW. Economic burden of healthcare-associated infections: An American perspec- tive. Expert Review of Pharmacoeconomics & Outcomes Research. 2009;9:417-422 [27] O'Neill J; on behalf of the Review on Antimicrobial Resistance...
Antimicrobial resistance: What is being done? It has been 8 years since the Review on Antimicrobial Resistance “Tackling Drug-Resistant Infections Globally” was published. This is often referred to more colloquially as “The O’Neill report on antimicrobial resistance”. Read more Terms...
(EuJIM) is an international, peer reviewed journal that aims to publish high quality, rigorous and ethical research on a wide range of complementary and integrative health care disciplines from across the globe. We welcome submissions that aim to inform …View...
Antibiotics that target Gram-negative bacteria in new ways are needed to resolve the antimicrobial resistance crisis1,2,3. Gram-negative bacteria are protected by an additional outer membrane, rendering proteins on the cell surface attractive drug targets4,5. The natural compound darobactin targets ...